2026 NPPES data Corneal and Contact Management Optometrist NPI 1821125436 OD
Verify on CMS →

DAVID FEENSTRA, OD

Corneal and Contact Management Optometrist in ORLANDO, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
72
Medicare Part D claims · 60 beneficiaries · Corneal and Contact Management Optometrist avg: 235
Generic prescribing
51%
generic claims · 49% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$20.84
1 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: DAVID FEENSTRA, OD is a Corneal and Contact Management Optometrist ([object Object]) practicing in ORLANDO, Florida with a Medicare Part D prescribing footprint of 72 claims across 60 beneficiaries — 49% brand-name prescribing . Industry payments of $20.84 across 1 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: DAVID FEENSTRA, OD filed 72 Medicare Part D claims in 2023 across ORLANDO, Florida. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

DAVID FEENSTRA, OD at a glance

Quality data not reported

NPI registry status

Active

Issued 02/28/2007

NPI 1821125436

Primary specialty

Corneal and Contact Management Optometrist

Niche

1,549 US NPIs in this specialty

Medicare Part D claims

72 69% vs specialty avg

2023 prescription claims

Specialty avg: 235

Specialty distribution in Florida

How Corneal and Contact Management Optometrist compares to other specialties among Florida providers

Florida providers

Corneal and Contact Management Optometrist share within Florida

1. Corneal and Contact Management Optometrist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Corneal and Contact Management Optometrist share within Florida

Specialty board-certification context

Estimated specialty board-certified rate — Corneal and Contact Management Optometrist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Corneal and Contact Management Optometrist ABMS/AOA estimate

Est. board-certified rate (Corneal and Contact Management Optometrist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Corneal and Contact Management Optometrist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

DAVID FEENSTRA, OD is a Corneal and Contact Management Optometrist provider practicing in ORLANDO, Florida, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: OD. NPI: 1821125436. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

DAVID FEENSTRA, OD appears in the CMS NPPES registry as a Corneal and Contact Management Optometrist provider holding OD credentials at 7008 W COLONIAL DR, ORLANDO, FL, 32818, with a listed phone of (407) 294-5648. NPI 1821125436 was issued on 02/28/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what FEENSTRA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 72 prescription claims written by this provider, covering 60 Medicare beneficiaries and totaling roughly $6K in drug spend, split 49% brand-name and 51% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Corneal and Contact Management Optometrist is a narrow specialty nationwide, with 1,549 enrolled providers across 52 states and an average of 235 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

7008 W COLONIAL DR
ORLANDO, FL 32818

Provider Details

NPI 1821125436
Specialty Corneal and Contact Management Optometrist
Credentials OD
Gender Male
NPI Issued 02/28/2007

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for DAVID FEENSTRA, OD. Source: openpaymentsdata.cms.gov.

Total received

$21

Largest payer

Bausch & Lomb Americas Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to DAVID FEENSTRA, OD. To verify DAVID FEENSTRA, OD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

DAVID FEENSTRA, OD — brand share 49.0%
Specialty average (est.)

49% brand-name claims vs 51% generic, on 72 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

72
Total Claims
$6K
Total Drug Cost
60
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
73
Total Day Supply
1,261
Brand vs Generic
49% brand / 51% generic
Brand Drug Cost
$4K
Generic Drug Cost
$2K

Patient Demographics

Average Patient Age
72.7 years
Avg HCC Risk Score
1.68
Gender Split
73% female / 27% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Tobramycin-Dexamethasone
Tobramycin/Dexamethasone
40
Prednisolone Acetate
24

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Corneal and Contact Management Optometrist Overview

How DAVID FEENSTRA, OD fits within the Corneal and Contact Management Optometrist landscape nationally.

1,549
Corneal and Contact Management Optometrist Providers in US
52
States with Corneal and Contact Management Optometrist
235
Avg Claims per Provider

DAVID FEENSTRA, OD's 72 claims are below the specialty average of 235.

Nearby Corneal and Contact Management Optometrist Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as FEENSTRA.

Compare Corneal and Contact Management Optometrist nationally: see state-by-state distribution →

Frequently Asked Questions

What is DAVID FEENSTRA, OD's specialty?
DAVID FEENSTRA, OD specializes in Corneal and Contact Management Optometrist and practices in ORLANDO, Florida. Credentials: OD.
How much does DAVID FEENSTRA, OD prescribe under Medicare Part D?
In 2023, DAVID FEENSTRA, OD wrote 72 Medicare Part D claims totaling $6K in drug costs for 60 beneficiaries.
Where is DAVID FEENSTRA, OD located?
DAVID FEENSTRA, OD is located at 7008 W COLONIAL DR, ORLANDO, FL, 32818. Phone: (407) 294-5648.
What is DAVID FEENSTRA, OD's NPI number?
DAVID FEENSTRA, OD's National Provider Identifier (NPI) is 1821125436, issued on 02/28/2007.
Does DAVID FEENSTRA, OD prescribe more brand-name or generic drugs?
DAVID FEENSTRA, OD's prescribing is 49% brand-name and 51% generic drugs by claim count, with $4K in brand drug costs.
How many Corneal and Contact Management Optometrist providers are there in the US?
There are 1,549 Corneal and Contact Management Optometrist providers across 52 states in the US. The average Corneal and Contact Management Optometrist provider writes 235 Medicare Part D claims per year.
What drugs does DAVID FEENSTRA, OD prescribe most often?
Based on 2023 Medicare Part D data, DAVID FEENSTRA, OD's most frequently prescribed drugs include Tobramycin-Dexamethasone, Prednisolone Acetate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does DAVID FEENSTRA, OD accept Medicare?
DAVID FEENSTRA, OD appears in CMS Medicare data with 72 Part D claims and 60 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify DAVID FEENSTRA, OD's credentials?
DAVID FEENSTRA, OD's NPI is 1821125436 with credentials OD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology